1 Ventilator-associated pneumonia (VAP) is defined as a pneumonia occurring in patients under mechanical ventilation for at least 48 hours and characterized by the presence of a new or progressive infiltrate, s
Biomarkers for ventilator-associated pneumonia: review of the literature.[J].Heart and Lung: The Journal of Critical Care 2011,4(4).Palazzo SJ, Simpson T, Schnapp L. Biomarkers for ventilator - asso- ciated pneumonia: review of the literature [ J ]. Heart Lung, 2011, 40(4) : 293 -...
We investigated if evolution towards resistance was associated with virulence changes, in the context of.ventilator-associated pneumonia (VAP). Four patients were selected because they had multiple VAP episodes during short periods (12 days to 5 weeks), with emergence of resistance. We performed ...
BACKGROUND:Ventilator-associated pneumonia (VAP) is a nosocomial infection commonly seen in patients in intensive care units (ICU). This study aimed to analyze factors affecting prognosis of patients diagnosed with VAP. MATERIAL AND METHODS:Critically il
Ventilator-associated pneumonia (VAP), the commonest ICU-acquired infection [3], can be challenging to diagnose as a range of non-infectious diseases may mimic the clinical picture of radiographic infiltrates, systemic inflammation and impaired oxygenation that typifies VAP [12]. To limit overdiagnosi...
Ventilator-associated pneumonia (VAP) is one of the most frequent ICU-acquired infections. Reported incidences vary widely from 5 to 40% depending on the setting and diagnostic criteria. VAP is associated with prolonged duration of mechanical ventilation and ICU stay. The estimated attributable mortal...
Ventilator-associated pneumonia (VAP) is a common cause of nosocomial infection, and is related to significant utilization of health-care resources. In the past decade, new data have emerged about VAP epidemiology, diagnosis, treatment and prevention. ...
ImpMyrianthefs P,Ioannidis K,Mis M,et al.Ventilator-associated pneumonia and Clinical Pulmonary Infection Score validation in a Greek general intensive care unit.Journal of Critical Care. 2005Myrianthefs, P., Ioannidis, K., Mis, M., Karatzas, S., & Baltopoulos, G. (2005). Ventilator-...
The influence of bronchoscopic techniques for diagnosing ventilator-associated pneumonia on antibiotic prescription: D.C.J.J. Bergmans 1, M.J.M. Bonten 1, F.H. van Tiel 2, C.A. Gaillard 3, P.W. de Leeuw 1, S. van der Geest 1, E.E. Stobberingh 2. Departments of of 1 Internal...
Overall development of ventilator associated pneumonia (VAP) (%) 33 (34.74) 11 (30.50) 0.651b Median VAP ventilator days (IQR) 14 (12) 10 (9) 0.757a Death due to VAP (%) 6 (6) 1(3) 0.7648c VAP rate per 1000 ventilator days 18 12 0.127 a Mann–Whitney test with 95% confidence...